BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27323397)

  • 1. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
    Lee S; Cho YE; Kim SH; Kim YJ; Park JH
    Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
    Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
    J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase regulates the nucleoplasmic translocation and stability of nucleolar GLTSCR2 protein.
    Lee S; Cho YE; Kim YJ; Park JH
    Biochem Biophys Res Commun; 2016 Mar; 472(1):95-100. PubMed ID: 26903295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.
    Lee S; Kim JY; Kim YJ; Seok KO; Kim JH; Chang YJ; Kang HY; Park JH
    Cell Death Differ; 2012 Oct; 19(10):1613-22. PubMed ID: 22522597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
    Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
    Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
    Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
    Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
    Kim JY; Cho YE; Park JH
    Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
    Moulin S; Llanos S; Kim SH; Peters G
    Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p14ARF through subnuclear compartmentalization.
    Gjerset RA; Bandyopadhyay K
    Cell Cycle; 2006 Apr; 5(7):686-90. PubMed ID: 16627991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
    Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y
    Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
    García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
    Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARF function does not require p53 stabilization or Mdm2 relocalization.
    Korgaonkar C; Zhao L; Modestou M; Quelle DE
    Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ARF-B23 connection: implications for growth control and cancer treatment.
    Zhang Y
    Cell Cycle; 2004 Mar; 3(3):259-62. PubMed ID: 14726681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
    Kuo ML; den Besten W; Thomas MC; Sherr CJ
    Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1 promotes the tumor suppressor function of p14
    Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
    EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.